Perceptive Advisors’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.9M Buy
+6,993,646
New +$15.9M 0.59% 40
2021
Q3
Sell
-1,640,957
Closed -$10.4M 143
2021
Q2
$10.4M Sell
1,640,957
-513,017
-24% -$3.25M 0.13% 107
2021
Q1
$16.7M Sell
2,153,974
-423,069
-16% -$3.27M 0.21% 82
2020
Q4
$16.9M Hold
2,577,043
0.18% 93
2020
Q3
$17.1M Hold
2,577,043
0.25% 70
2020
Q2
$21.5M Sell
2,577,043
-676,880
-21% -$5.64M 0.35% 57
2020
Q1
$25M Hold
3,253,923
0.65% 39
2019
Q4
$27M Hold
3,253,923
0.54% 42
2019
Q3
$24M Buy
3,253,923
+100,000
+3% +$738K 0.65% 36
2019
Q2
$35.4M Sell
3,153,923
-20,000
-0.6% -$224K 0.81% 32
2019
Q1
$34.1M Buy
3,173,923
+262,208
+9% +$2.82M 0.96% 30
2018
Q4
$43.6M Buy
2,911,715
+250,000
+9% +$3.74M 1.66% 17
2018
Q3
$49.2M Buy
2,661,715
+740,000
+39% +$13.7M 1.32% 24
2018
Q2
$43.9M Sell
1,921,715
-287,097
-13% -$6.56M 1.15% 28
2018
Q1
$62.8M Sell
2,208,812
-281,569
-11% -$8.01M 1.76% 16
2017
Q4
$52.6M Buy
2,490,381
+1,100,000
+79% +$23.2M 1.74% 14
2017
Q3
$25.3M Hold
1,390,381
0.97% 23
2017
Q2
$21.6M Sell
1,390,381
-140,278
-9% -$2.17M 1.08% 27
2017
Q1
$26.4M Buy
1,530,659
+606,896
+66% +$10.5M 1.51% 20
2016
Q4
$10.2M Buy
+923,763
New +$10.2M 0.72% 34
2016
Q3
Sell
-742,021
Closed -$7.58M 196
2016
Q2
$7.58M Hold
742,021
0.53% 41
2016
Q1
$9.57M Buy
742,021
+99,974
+16% +$1.29M 0.84% 26
2015
Q4
$13.4M Buy
+642,047
New +$13.4M 0.99% 25